October 25, 2010 – A new study shows that an intensive population management program that matches heart disease patients to personal nurses and clinical pharmacy specialists not only reduces the risk of death but also reduces health care costs. The study, from Kaiser Permanente Colorado, will be published in the November issue of Pharmacotherapy.

October 21, 2010 – Vascular Solutions has acquired the assets related to snare products from Radius Medical Technologies and its subsidiary, Radius Medical, LLC. Vascular Solutions has been selling the Expro Elite and Micro Elite snares in the United States under a distribution agreement since 2008.

October 21, 2010 – Daniel S. Berman, M.D., an innovator of cardiac imaging technology for 30 years, has received the Pioneer in Medicine Award from Cedars-Sinai Medical Center, its highest honor.

October 20, 2010 - The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched the first large-scale, multicenter study to investigate the effectiveness of body cooling treatment in infants and children who have had cardiac arrest.

October 20, 2010 - The U.S. Food and Drug Administration (FDA) approved a new drug to help prevent stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). Pradaxa (generic: dabigatran etexilate), by Boehringer Ingelheim Pharmaceuticals, will be available in 75 mg and 150 mg capsules.

October 19, 2010 – A new high-definition (HD) technology reduces blur created by respiration during positron emission tomography/computed tomography (PET/CT) studies. The Siemens HD Chest provides full HD lesion detection and improved standardized uptake value (SUV) quantification.